Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.2300 (-6.39%) ($6.2300 - $6.2300) on Mon. Sep. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.4% (three month average) | RSI | 41 | Latest Price | $6.2300(-6.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -5.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(70%) ARKK(67%) IWO(65%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -1.7% in a week (0% probabilities). VIXM(-49%) VXX(-36%) UUP(-12%) TLT(-7%) IGOV(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.7% (StdDev 3.4%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.6 | 5 Day Moving Average | $6.26(-0.48%) | 10 Day Moving Average | $6.43(-3.11%) | 20 Day Moving Average | $6.6(-5.61%) | To recent high | -29.2% | To recent low | 7.2% | Market Cap | $515m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |